N-Acetyl Semax
Price and cost-per-mg comparison
N-Acetyl-Semax is an acetylated derivative of semax (MEHFPGP), the synthetic ACTH(4-7)PGP heptapeptide nootropic and neuroprotective compound developed in Russia; N-acetylation is proposed to improve enzymatic stability and CNS pharmacokinetics relative to the parent compound, with the expectation that the acetylated form retains semax receptor interactions and neurotrophic effects with potentially greater bioavailability. Semax itself modulates BDNF and NGF expression, influences dopaminergic and serotonergic activity, and has been studied in Russian clinical trials for ischemic stroke and cognitive disorders; N-acetyl-semax is marketed as an enhanced analog on the basis of these parent compound properties. No publications indexed in PubMed specifically examine N-acetyl-semax as a distinct compound; no human clinical trials, independent preclinical studies, or pharmacokinetic data for this specific acetylated form appear in the indexed scientific literature, meaning all claims about this compound are extrapolations from the parent compound evidence base. N-Acetyl-Semax has no FDA approval and no approved indication in any jurisdiction; it is available through research chemical suppliers as an analog of a Russia-approved compound, but its independent pharmacological properties and human safety profile are entirely uncharacterized as a distinct molecule. Semax variant landscape: N-Acetyl-Semax sits alongside several related analogs in the research compound market. The base compound semax (approved in Russia, primarily used intranasally) is the most evidence-backed form. Semax amidate and N-acetyl semax amidate add C-terminal amidation — another stability modification proposed to further reduce enzymatic cleavage. Research suppliers sometimes list "N-Acetyl Semax Amidate" as a combined modification compound. All variant claims trace back to the parent semax pharmacology; independent validation of each structural modification's effect on human CNS pharmacokinetics does not exist in published literature. Administration: N-Acetyl-Semax is most commonly used as a nasal spray solution, mirroring the intranasal route of approved semax in Russia. This route is proposed to allow absorption via the olfactory epithelium for partial CNS delivery. Cognitive peptide providers offering semax-class compounds are listed in the PeptideBase cognitive peptides directory.
Learn more ↗Compare listings
Filter by vial size and quantity — the figures and table follow.
| Vendor | Size | Price | Cost per mg▲ | COA | Source | Availability | Actions |
|---|---|---|---|---|---|---|---|
5 mgsingle vials2 listingsmedian $7.30 / mg | |||||||
US N-Acetyl Semax Amidate | 5 mg vial | $28.00 | $5.60Lowest | — | Vendor feed · 2 wk ago | In stock | View ↗ |
US N-ACETYL-SEMAX SPRAY 5MG | 5 mg vial | $45.00 | $9.00 | Vendor feed · 8 wk ago | — | View ↗ | |
Other sizessingle vials, one listing each2 listingsmedian $3.34 / mg | |||||||
US N-Acetyl Semax Amidate | 30 mg vial | $100.34 | $3.34 | — | Vendor feed · 2 wk ago | In stock | View ↗ |
US N-Acetyl Semax Amidate | 60 mg vial | $200.69 | $3.34 | — | Vendor feed · 2 wk ago | In stock | View ↗ |
— in COA: no certificate on file for this vendor— in availability: stock not read at the last checkPrices as scraped; foreign prices converted to USD
When N-Acetyl Semax prices moved
0 days in the last 120 on which a feed run read comparable N-Acetyl Semax prices from 3 or more vendors. Each point is the median $/mg across every comparable listing read that day, sized by how many vendors were read. A log of run days, not a continuous series.
How these prices are computed
The short version. The methodology page has the rest.
Source
Prices are read from each vendor's own store feed or product markup (Vendor feed). Every row says which source it came from and when it was read. Prices parsed from page text are not in this index.
$/mg
Listed price ÷ stated milligrams, converted to USD. Packs are priced on total milligrams. Listings sold per kit, per ml, as capsules or sprays, as blends, or without a stated mass are shown but not ranked.
Population
Active online research vendors only. Clinic, pharmacy and telehealth prices are excluded. Medians and the p25–p75 band are computed over comparable listings, one row per vendor product and size.
Independence. Ranking in this index: 0 paid placements.
PeptideBase accepts no payment for inclusion in this index.
PeptideBase takes no affiliate commission on vendor sales.
Ordering is by price, from scraped data.
Educational research tools — not medical advice.